In Vitro Diagnostics | Medtech 360 | 2017 | US | Market Analysis
The US market for IVDs will exhibit moderate growth through 2025, driven by favorable demographics and strong growth in the MDx market.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IVDs in the US across a 10-year period.
The use of MDx tests will expand rapidly over the forecast period
Which MDx tests will experience the highest growth throughout the forecast period?
How will adoption of MDx tests affect the other test segments in the IVD market?
Reference laboratories in the US will become increasingly centralized over the forecast period.
How are vendors adjusting their strategies to adapt to this trend?
How will test volumes shift between the different facility types for specific types of tests?
The IVD competitive landscape consists of large MNCs as well as smaller niche competitors specializing in specific segments and diseases.
Which companies were leading the IVD market in 2016?
How do strategies differ between MNCs and smaller companies in this space?
What are the key purchasing criteria laboratories consider when selecting an IVD manufacturer?
